Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

62 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

WTZ-GIST-09-01 (Imatinib + LBH589) Additional Cycle lab results Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Additional Cycle lab results Haematology 2009-011417-24

- 01.12.16 - 1 Formular, 2 Itemgruppen, 15 Datenelemente, 1 Sprache
Itemgruppen: Chemotherapy Regimen, Laboratory Tests
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Additional week laboratory results Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Additional week laboratory results Blood/ Urinanalysis 2009-011417-24

- 01.12.16 - 1 Formular, 3 Itemgruppen, 32 Datenelemente, 1 Sprache
Itemgruppen: Chemotherapy Regimen, Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Blood/ Urinanalysis 2009-011417-24

- 01.12.16 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Blood/ Urinanalysis 2009-011417-24

- 23.11.16 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 Week 9 (V10) 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 Week 9 (V10) 2009-011417-24

- 23.11.16 - 1 Formular, 1 Itemgruppe, 16 Datenelemente, 1 Sprache
Itemgruppe: Vital signs
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Haematology 2009-011417-24

- 23.11.16 - 1 Formular, 1 Itemgruppe, 20 Datenelemente, 1 Sprache
Itemgruppe: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Blood/ Urinanalysis 2009-011417-24WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24

- 23.11.16 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 Week 8 (V9) 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 Week 8 (V9) 2009-011417-24

- 23.11.16 - 1 Formular, 1 Itemgruppe, 15 Datenelemente, 1 Sprache
Itemgruppe: Vital signs
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Haematology 2009-011417-24

- 23.11.16 - 1 Formular, 1 Itemgruppe, 20 Datenelemente, 1 Sprache
Itemgruppe: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Haematology 2009-011417-24

- 23.11.16 - 1 Formular, 1 Itemgruppe, 20 Datenelemente, 1 Sprache
Itemgruppe: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 Week 7 (V8) 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 Week 7 (V8) 2009-011417-24

- 23.11.16 - 1 Formular, 1 Itemgruppe, 15 Datenelemente, 1 Sprache
Itemgruppe: Vital signs
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24

- 23.11.16 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video